Micro-k and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micro-k (potassium chloride) and Levaquin (levofloxacin). Common drug interactions include dyspnoea among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Micro-k and Levaquin. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.



On Jul, 19, 2026

92 people who take Micro-k and Levaquin together, and have interactions are studied.

Micro-k and Levaquin drug interactions.

What are the common drug interactions of Micro-K and Levaquin, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal pain
  3. Cardiomegaly (increased size of heart than normal)
  4. Anaemia (lack of blood)
  5. Oedema peripheral (superficial swelling)
  6. Pleural effusion (water on the lungs)
  7. Renal failure (kidney dysfunction)
  8. Arthralgia (joint pain)
  9. Bradycardia (abnormally slow heart action)
  10. Cardiac arrest

male:

  1. Arthralgia (joint pain)
  2. Fatigue (feeling of tiredness)
  3. Renal failure (kidney dysfunction)
  4. Anxiety
  5. Cataract (clouding of the lens inside the eye)
  6. Cough
  7. Haematuria (presence of blood in urine)
  8. Hypersomnia (excessive daytime sleepiness (eds))
  9. Injury
  10. Metastases to bone (cancer spreads to bone)

What are the common drug interactions of Micro-K and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Accident
  2. Affective disorder (mental disorder)
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  4. Anaemia (lack of blood)
  5. Anxiety
  6. Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
  7. Aortic valve incompetence
  8. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  9. Arthralgia (joint pain)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

40-49:

  1. Pain
  2. Acute respiratory failure
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Aortic calcification (aortic calcification sign of heart valve disease)
  9. Aortic valve incompetence
  10. Application site pain

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Cough
  3. Decreased appetite
  4. Haematochezia (passage of stools containing blood)
  5. Arthropathy
  6. Depression
  7. Discomfort
  8. Emotional distress
  9. Exostosis (formation of new bone on the surface of a bone)
  10. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)

60+:

  1. Anaemia (lack of blood)
  2. Cardiac failure congestive
  3. Anxiety
  4. Bradycardia (abnormally slow heart action)
  5. Abdominal pain
  6. Cardiomegaly (increased size of heart than normal)
  7. Renal failure (kidney dysfunction)
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Cataract (clouding of the lens inside the eye)
  10. Depression

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 13.04%
  2. Stress And Anxiety: 8 people, 8.70%
  3. Pain: 6 people, 6.52%
  4. Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 5 people, 5.43%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 5.43%
  6. Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 5.43%
  7. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Micro-k and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micro-k and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride and levofloxacin (the active ingredients of Micro-k and Levaquin, respectively), and Micro-k and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: